Last reviewed · How we verify

A Study to Evaluate the Impact of Activated Charcoal on the Absorption of LY2140023 in Healthy Subjects

NCT01609218 Phase 1 COMPLETED Results posted

The study will evaluate the effect of activated charcoal on absorption of LY2140023. The study involves a single dose of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth 2 times during study (once with activated charcoal, once without activated charcoal). This study will last approximately 16 days, not including screening. Screening is required within 28 days prior to study entry.

Details

Lead sponsorDenovo Biopharma LLC
PhasePhase 1
StatusCOMPLETED
Enrolment27
Start date2012-06
Completion2012-09

Conditions

Interventions

Primary outcomes

Countries

United Kingdom